Skip to main content
. 2022 Aug 13;9(4):561–567. doi: 10.1007/s40801-022-00323-5

Table 3.

Most frequently prescribed antimicrobials and indications for prophylaxis, by body systema

All antimicrobials [systemic and topical] (n = 4739)
Rank Urinary tract (54.3%, n = 2575) Skin, soft tissue or mucosal (18.1%, n = 858) Respiratory tract (7.3%, n = 348)
Antimicrobial/indication No. % Antimicrobial/indication No. % Antimicrobial/indication No. %
1 Cefalexin 1035 40.2 Clotrimazole 371 43.2 Doxycycline 173 49.7
2 Methenamine hippurate 879 34.1 Cefalexin 117 13.6 Cefalexin 31 8.9
3 Trimethoprim 239 9.3 Doxycycline 55 6.4 Azithromycin 25 7.2
1 Cystitis 1681 65.3 Other skin, soft tissue or mucosal 473 55.1 Infective exacerbation of COPD 121 34.8
2 Other—urinary 397 15.4 Wound infection: non-surgical 96 11.2 Pneumonia 84 24.1
3 Asymptomatic bacteriuria 272 10.6 Tinea 83 9.7 Other—respiratory tract 78 22.4
Systemic antimicrobials only (n = 3923)
Rank Urinary tract (65.5%, n = 2571) Respiratory tract (8.9%, n = 348) Skin, soft tissue or mucosal (7.3%, n = 288)
Antimicrobial/indication No. % Antimicrobial/indication No. % Antimicrobial/indication No. %
1 Cefalexin 1035 40.2 Doxycycline 173 49.7 Cefalexin 117 40.6
2 Methenamine hippurate 879 34.1 Cefalexin 31 8.9 Doxycycline 55 19.1
3 Trimethoprim 239 9.3 Azithromycin 25 7.2 Amoxicillin—clavulanic acid 17 5.9
1 Cystitis 1681 65.4 Infective exacerbation of COPD 121 34.8 Other—skin, soft tissue or mucosal 76 26.4
2 Other—urinary tract 394 15.3 Pneumonia 84 24.1 Cellulitis 64 22.2
3 Asymptomatic bacteriuria 272 10.6 Other—respiratory tract 78 22.4 Wound infection: non-surgical 63 21.9

COPD chronic obstructive pulmonary disease

a132 unknown indications for which an associated body system could not be assigned excluded from total numbers

Not detailed in the table, 8.2% and 9.7% of all and systemic-only prophylactic antimicrobials, respectively, were prescribed for medical prophylaxis indications